ARTICLE | Company News
Sunesis, Merck deal
August 2, 2004 7:00 AM UTC
The companies partnered to develop small molecule compounds from Sunesis to treat viral infections. Sunesis will use its Tethering fragment-based discovery technology to identify fragments that bind w...